Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Contineum Therapeutics Inc CTNM
$13.70
▼ -1.15%
($-0.16)
Open
$13.85
Prev Close
$13.86
Day Range
$13.35 – $14.05
52W Range
$3.35 – $16.33
Market Cap
$506.96M
Beta
0.27
EPS (TTM)
$-1.95
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-04-05 |
| Shares Out. | 37,390,000 |
| Website | contineum-tx.com/ ↗ |
| Phone | 18583335280 |
Contineum Therapeutics Inc is a publicly traded company under the ticker symbol CTNM on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-05-01)